首页> 外国专利> Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal dysfunctions including inflammation in the gastro-intestinal tract, neonatal necrotizing enterocolitis (nec) and bacterial sepsis

Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal dysfunctions including inflammation in the gastro-intestinal tract, neonatal necrotizing enterocolitis (nec) and bacterial sepsis

机译:用于预防和/或治疗胃肠道功能障碍(包括胃肠道炎症,新生儿坏死性小肠结肠炎(nec)和细菌性败血症)的口服革兰氏(+)细菌和谷氨酰胺组合物

摘要

A composition and method for treating and preventing gastro-intestinal injury are disclosed. The composition includes a combination of Gram (+) bacteria, in particular Lactobacillus and/or Bifidobacteria, and glutamine. The method involves orally or naso-gastrically administering a composition containing Gram (+) bacteria, in particular Lactobacillus, and glutamine. The composition, which blocks translocation of bacterial agents such as Gram (−) bacteria, other infectious agents, toxins, chemicals and injurious substances, may be used in the prevention and treatment of symptoms and/or disease that result from translocation of Gram (−) bacteria, including inflammation in the gastro-intestinal tract, Neonatal Necrotizing Enterocolitis (NEC) and bacterial sepsis.
机译:公开了一种用于治疗和预防胃肠道损伤的组合物和方法。该组合物包括革兰氏(+)细菌,特别是乳杆菌和/或双歧杆菌,与谷氨酰胺的组合。该方法涉及口服或鼻胃给药含革兰氏(+)细菌,特别是乳杆菌和谷氨酰胺的组合物。该组合物可阻止细菌如革兰氏(+)细菌,其他传染原,毒素,化学物质和伤害性物质的移位,可用于预防和治疗因革兰氏移位而引起的症状和/或疾病( (−)细菌,包括胃肠道炎症,新生儿坏死性小肠结肠炎(NEC)和细菌性败血症。

著录项

  • 公开/公告号US2004096427A1

    专利类型

  • 公开/公告日2004-05-20

    原文格式PDF

  • 申请/专利权人 PANIGRAHI PINAKI;

    申请/专利号US20030275171

  • 发明设计人 PINAKI PANIGRAHI;

    申请日2003-10-02

  • 分类号A61K45/00;A61K31/198;

  • 国家 US

  • 入库时间 2022-08-21 23:21:00

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号